Along with ACE inhibition leading to an accumulation of bradykinin and substance P, both potential inducers of tumor proliferation, ACE inhibition can also lead to an increase in Ac-SDKP, an endogenous antifibrotic peptide that is capable of inducing angiogenesis [71]. This evidence concerns the gene ACE and neoplasm.